Intranasal administration of white tea alleviates the olfactory function deficit induced by chronic unpredictable mild stress

Pharm Biol. 2020 Dec;58(1):1221-1228. doi: 10.1080/13880209.2020.1855213.

Abstract

Context: White tea [Camellia sinensis (L) O.Ktze. (Theaceae)] is popular in Asia, but its benefits on olfactory injury are unknown.

Objective: The present study explores the effects of white tea on the olfactory injury caused by chronic unpredictable mild stress (CUMS).

Materials and methods: C57BL/6J mice (WT) were exposed to CUMS. CUMS mice (CU) were intranasally treated with white tea extract [low tea (LT), 20 mg/kg; high tea (HT), 40 mg/kg] and fluoxetine (CF, 20 mg/kg) for 7 days. Several behavioural tests were conducted to assess depression and olfactory function. The transmission electron microscope (TEM) and semi-quantitative reverse transcription PCR were performed separately to observe the changes of related structures and genes transcription level.

Results: The depressive behaviours of the LT and HT mice were reversed. The latency time of the buried food pellet test decreased from 280 s (CU) to 130 s (HT), while the olfactory sensitivity and olfactory avoidance test showed that the olfactory behaviours disorder of LT and HT mice were alleviated. The white tea increased the A490 nm values of the cortisol treated cells from 0.15 to 1.4. Reduced mitochondrial and synaptic damage in the olfactory bulb (OB), enhanced expression of the brain-derived neurotrophic factor (BDNF) and olfactory marker protein (OMP) were observed in the LT and HT mice.

Conclusions and discussion: White tea has the potential in curing the olfactory deficiency related to chronic stress. It lays the foundation for the development of new and reliable drug to improve olfactory.

Keywords: BDNF; Mitochondria; OMP; behavioural experiment.

MeSH terms

  • Administration, Intranasal
  • Animals
  • Antidepressive Agents, Second-Generation / pharmacology
  • Behavior, Animal / drug effects
  • Brain-Derived Neurotrophic Factor / metabolism
  • Camellia sinensis / chemistry*
  • Chronic Disease
  • Depression / drug therapy
  • Fluoxetine / pharmacology
  • Gene Expression / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Motor Activity / drug effects
  • Olfaction Disorders / drug therapy*
  • Olfaction Disorders / etiology*
  • Olfaction Disorders / psychology
  • Olfactory Bulb / pathology
  • Plant Extracts / administration & dosage*
  • Plant Extracts / therapeutic use*
  • Plant Extracts / toxicity
  • Stress, Psychological / complications*
  • Stress, Psychological / drug therapy*
  • Stress, Psychological / psychology
  • Tea / chemistry*

Substances

  • Antidepressive Agents, Second-Generation
  • Bdnf protein, mouse
  • Brain-Derived Neurotrophic Factor
  • Plant Extracts
  • Tea
  • Fluoxetine

Grants and funding

This work was supported by the Science and Technology Commission of Shanghai Municipality [16DZ2348900] and DaXia Programs of Innovation and Entrepreneurship for Undergraduates [201710269205X].